ArticlesRegulatory October 5, 2024 2024 Global Biopharma Sustainability Review CytivaThis report is based on data from 800 pharma and biopharma professionals at director-level and… Ross Burns
ArticlesRegulatoryUpstream September 6, 2024 Considering Process Scaling for Monoclonal Antibodies During Early Phase Development Successful biomanufacturing processes not only provide the desired product in high yield and purity, they… Ross Burns
ArticlesRegulatory August 8, 2024 Address the complexity of protein characterization Since the FDA approved the first monoclonal based therapy in 1985, mAbs have had significant… Ross Burns
ArticlesMultimediaRegulatoryRegulatory June 13, 2024 Extractables in single-use systems used in ADC manufacturing, Part 2. We performed extractables studies on single-use chromatography and tangential flow filtration systems using common solvents… Ross Burns
ArticlesBioPharmaRegulatory April 5, 2024 Filtration methods to overcome new challenges in viral safety Read our article which summarizes the recent virus filtration regulatory changes in PDA Technical... admin-element
ArticlesRegulatory February 9, 2024 Paring Down Impurities in Downstream Processing Myriad choices confront manufacturers before they even consider optimizing downstream processes. admin-element
ArticlesRegulatory January 12, 2024 Dear lentivirus: We have not forgotten about you and how to improve your polishing recovery Lentiviruses are commonly used for both chimeric antigen receptor (CAR) T cell therapy and ex... admin-element
ArticlesRegulatory December 1, 2023 Getting your investigational drug regulatory ready Navigating regulatory requirements can be an overwhelming and time-consuming part of the translational... admin-element
ArticlesRegulatory August 25, 2023 A risk based approach to sterile filtration Drug quality cannot be assured only by finished-product testing. Process validation is required to... admin-element
ArticlesRegulatory June 13, 2023 Simulation gets therapies to patients faster and smarter Digital solutions are helping to decrease therapeutic time to market but remain challenging – learn… admin-element